Last Update: 08/04/2006 Printer Friendly Printer Friendly   Email This Page Email This Page  

All News releases related to Vaginitis
Your search for: All Related News Releases All Years returned the following 17 results:
09/11/08   Item of Interest: Public Comment on the DRAFT Pregnancy and Perinatology (PP) Branch Report to Council
Each component of the NICHD reports its activities to the National Advisory Child Health and Human Development (NACHHD) Council, the federal advisory committee for the NICHD. The NACHHD Council follows all regulations set forth in the Federal Advisory Committee Act.
09/10/08   Herpes Virus Changes Anti-Herpes Drug To Form That Hinders AIDS Virus
The drug acyclovir has long been used to suppress outbreaks of oral and genital herpes. Herpes viruses change acyclovir to a form that prevents them from reproducing. Now, it appears that after acyclovir is altered by herpes viruses, it also interferes with the AIDS virus’s ability to reproduce, report researchers from the National Institutes of Health and other institutions.
06/11/08   Item of Interest: Public Comment on the DRAFT Contraception and Reproductive Health (CRH) Branch Report to Council
Each component of the NICHD reports its activities to the National Advisory Child Health and Human Development (NACHHD) Council, the federal advisory committee for the NICHD. The NACHHD Council follows all regulations set forth in the Federal Advisory Committee Act
09/07/07   Item of Interest: Public Comment on the DRAFT Demographic and Behavioral Sciences (DBS) Branch Report to Council
Each component of the NICHD reports its activities to the National Advisory Child Health and Human Development (NACHHD) Council, the federal advisory committee for the NICHD. The NACHHD Council follows all regulations set forth in the Federal Advisory Committee Act.
08/23/04   Depo Provera Appears to Increase Risk for Chlamydial and Gonococcal Infections
The injectable contraceptive depot-medroxyprogesterone acetate (DMPA) appears to increase a woman's risk of acquiring the sexually transmitted infections chlamydia and gonorrhea by approximately three fold when compared to women not using a hormonal contraceptive, according to a study jointly funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) at the National Institutes of Health and the U.S. Agency for International Development's Office of Population and Reproductive Health.
07/09/04   Thai Study Shows That Inexpensive Treatment Reduces Risk Of Mother To Child HIV Transmission
A single dose of the drug nevirapine given at the beginning of labor, when combined with a short course of the anti-HIV drug AZT (zidovudine), dramatically reduces a woman's chances of passing HIV on to her child, according to a study of Thai women funded in part by the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health.
06/30/04   Multivitamins During Pregnancy and After Birth Delay Progression of HIV In Women
Multivitamin supplements containing high doses of the vitamin B complex, as well as vitamins C and E, given to HIV-infected women during pregnancy and for more than 5 years after they gave birth reduced the symptoms of AIDS, according to a study of Tanzanian women supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the John E. Fogarty International Center (FIC) for Advanced Study in the Health Sciences, both of the National Institutes of Health. The supplements also bolstered counts of disease-fighting immune cells, and modestly lowered HIV levels in the blood.
06/16/04   Analysis Shows Infants of Mothers Infected With HIV Face Nearly Constant Risk For HIV Infection For Duration of Breastfeeding
After four weeks of age, infants who breast feed from mothers infected with HIV continue to be at risk for infection with HIV for as long as they breastfeed, according to an analysis conducted and funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health. Previously, researchers thought the risk for being infected with the virus from breast milk diminished as an infant grew older.
06/23/03   Vulvodynia Workshop Highlights Prevalence of Disorder Scientists Share Findings on Pain Research and New Therapies
Vulvodynia is a condition characterized by burning, stinging, irritation, or rawness of the female genital area when there is no apparent infection or skin disease that could cause these symptoms.
06/12/02   Study Concludes Benefits of Anti-HIV Therapy During Pregnancy Outweigh Risks
A new study found no association between the use of an anti-HIV treatment that uses a combination of drugs during pregnancy and an increased risk of such birth complications as premature delivery, stillbirth, and low Apgar scores.
10/31/01   Harmless Virus Prevents HIV Variant From Spreading In Human Tissue Blocks
Human herpesvirus 6 (HHV-6), a common virus that is apparently harmless in adults, appears to prevent a form of the AIDS virus from reproducing in laboratory cultures of human tissue, according to a study published in the November issue of Nature Medicine.
08/15/01   Treatment for Common Sexually Transmitted Disease During Pregnancy Fails to Reduce the Likelihood of Premature Birth
Using the drug metronizadole to treat pregnant women who have the sexually transmitted disease trichomoniasis does not reduce the women's chances for giving birth prematurely, and may actually increase them, according to a study appearing in the August 16 New England Journal of Medicine.
07/27/01   NICHD Funds New Sites to Follow Disease Progression in HIV-Infected Women
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) will fund three sites to conduct research to increase understanding of how infection with the human immunodeficiency virus (HIV) affects adolescent and adult women.
10/04/00   Shorter AZT Treatment Reduces Mother to Child HIV Transmission as Well as Longer Treatment but for Less Cost
A shorter course of AZT therapy than currently prescribed for HIV-infected pregnant women may allow women in developing countries to afford the treatment that can reduce their babies' chances of contracting AIDS, but at a much lower cost, according to a study in the October 5 New England Journal of Medicine.
02/23/00   NICHD Study Shows Treatment Fails to Prevent Preterm Birth
In the largest study of its kind, antibiotic treatment to eliminate bacterial vaginosis failed to prevent premature birth, according to a study supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and coauthored by researchers at the NICHD and several other institutions.
Page      1   2   >

If you are a member of the media and have questions about an NICHD news release or research, or if you would like to schedule an interview with an NICHD scientist or grantee, please contact the Public Information and Communications Branch at 301-496-5133 or by fax at 301-496-7101.